Review
Copyright ©The Author(s) 2022.
World J Gastrointest Oncol. Jan 15, 2022; 14(1): 55-74
Published online Jan 15, 2022. doi: 10.4251/wjgo.v14.i1.55
Table 2 Helicobacter pylori infection effect in whole gastroenterology tract malignant diseases
Site
Malignant cell type
H. pylori effect
Odds ratio
95%CI
P value
Gastrointestinal transit time
Oral cavitySquamous cell carcinomaNon related1 min
Pharynx-larynxSquamous cell carcinomaIncreased risk12.871.71-4.84< 0.051 s
OesophagusSquamous cell carcinomaNon related4-8 s
AdenocarcinomaProtected effect0.560.46-0.68< 0.05
StomachAdenocarcinomaCause-effect5.93.4-10.3< 0.052-4 h
MALT lymphomaCause-effect1.961.0-3.9< 0.05
Small intestineLymphomaNon related6 h
ColorectumAdenocarcinomaPartial cause-effect1.71.64-1.76< 0.0510 h to days
LymphomaNon related